دورية أكاديمية
أعرض في EDS

Systematic Review and Meta-Analysis on MS-Based Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Bipolar Disorder.

التفاصيل البيبلوغرافية
العنوان: Systematic Review and Meta-Analysis on MS-Based Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Bipolar Disorder.
المؤلفون: Rodrigues JE; CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.; CIBB-Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal., Martinho A; CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.; CIBB-Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal., Santos V; CIBB-Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, 3004-504 Coimbra, Portugal.; Psychiatry Department, Centro Hospitalar e Universitário de Coimbra, 3004-561 Coimbra, Portugal., Santa C; CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.; CIBB-Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal., Madeira N; Faculty of Medicine, University of Coimbra, 3004-504 Coimbra, Portugal.; Psychiatry Department, Centro Hospitalar e Universitário de Coimbra, 3004-561 Coimbra, Portugal.; CIBIT-Coimbra Institute for Biomedical Imaging and Translational Research, University of Coimbra, 3000-548 Coimbra, Portugal., Martins MJ; CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.; CIBB-Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal.; Medical Services, University of Coimbra Medical Services, 3004-517 Coimbra, Portugal., Pato CN; Department of Psychiatry and Behavioral Sciences, SUNY Downstate Health Sciences University, Brooklyn, NY 11203, USA., Macedo A; Faculty of Medicine, University of Coimbra, 3004-504 Coimbra, Portugal.; Psychiatry Department, Centro Hospitalar e Universitário de Coimbra, 3004-561 Coimbra, Portugal.; CIBIT-Coimbra Institute for Biomedical Imaging and Translational Research, University of Coimbra, 3000-548 Coimbra, Portugal., Manadas B; CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.; CIBB-Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal.; III Institute for Interdisciplinary Research, University of Coimbra (IIIUC), 3030-789 Coimbra, Portugal.
المصدر: International journal of molecular sciences [Int J Mol Sci] 2022 May 13; Vol. 23 (10). Date of Electronic Publication: 2022 May 13.
نوع المنشور: Journal Article; Meta-Analysis; Review; Systematic Review
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI, [2000-
مواضيع طبية MeSH: Bipolar Disorder*/diagnosis , Proteomics*/methods, Biomarkers/metabolism ; Humans ; Mass Spectrometry/methods ; Proteome
مستخلص: Bipolar disorder (BD) is a clinically heterogeneous condition, presenting a complex underlying etiopathogenesis that is not sufficiently characterized. Without molecular biomarkers being used in the clinical environment, several large screen proteomics studies have been conducted to provide valuable molecular information. Mass spectrometry (MS)-based techniques can be a powerful tool for the identification of disease biomarkers, improving prediction and diagnosis ability. Here, we evaluate the efficacy of MS proteomics applied to human peripheral fluids to assess BD biomarkers and identify relevant networks of biological pathways. Following PRISMA guidelines, we searched for studies using MS proteomics to identify proteomic differences between BD patients and healthy controls (PROSPERO database: CRD42021264955). Fourteen articles fulfilled the inclusion criteria, allowing the identification of 266 differentially expressed proteins. Gene ontology analysis identified complement and coagulation cascades, lipid and cholesterol metabolism, and focal adhesion as the main enriched biological pathways. A meta-analysis was performed for apolipoproteins (A-I, C-III, and E); however, no significant differences were found. Although the proven ability of MS proteomics to characterize BD, there are several confounding factors contributing to the heterogeneity of the findings. In the future, we encourage the scientific community to use broader samples and validation cohorts, integrating omics with bioinformatics tools towards providing a comprehensive understanding of proteome alterations, seeking biomarkers of BD, and contributing to individualized prognosis and stratification strategies, besides aiding in the differential diagnosis.
References: Evid Based Ment Health. 2019 Nov;22(4):153-160. (PMID: 31563865)
Psychoneuroendocrinology. 2017 Dec;86:17-24. (PMID: 28910601)
Mol Psychiatry. 2017 May;22(5):666-679. (PMID: 28289283)
Lancet. 2020 Dec 5;396(10265):1841-1856. (PMID: 33278937)
Int J Bipolar Disord. 2017 Dec;5(1):7. (PMID: 28155207)
BMC Psychiatry. 2020 Apr 3;20(1):145. (PMID: 32245436)
Medicine (Baltimore). 2018 Dec;97(51):e13553. (PMID: 30572456)
Int J Neuropsychopharmacol. 2015 Dec 30;19(6):. (PMID: 26721951)
Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 5;147B(7):1270-7. (PMID: 18444252)
Encephale. 2015 Feb;41(1):10-6. (PMID: 24094986)
Mol Biosyst. 2014 Jun;10(6):1246-54. (PMID: 24554194)
J Affect Disord. 2013 Dec;151(3):1033-40. (PMID: 24060589)
BMC Genomics. 2019 Jul 11;20(Suppl 7):535. (PMID: 31291891)
Anal Bioanal Chem. 2015 Jan;407(3):661-7. (PMID: 25433685)
PLoS One. 2010 Jul 02;5(7):e11419. (PMID: 20625481)
N Engl J Med. 2020 Jul 2;383(1):58-66. (PMID: 32609982)
Mol Psychiatry. 2008 Dec;13(12):1118-28. (PMID: 17938634)
EBioMedicine. 2019 Jul;45:351-361. (PMID: 31229437)
Mol Psychiatry. 2009 Jun;14(6):601-13. (PMID: 18268500)
J Psychiatr Res. 2014 Sep;56:18-27. (PMID: 24862657)
Anal Chem. 2010 Jul 1;82(13):5859-64. (PMID: 20536186)
Adv Exp Med Biol. 2019;1118:63-70. (PMID: 30747417)
Medicine (Baltimore). 2018 Jul;97(27):e11089. (PMID: 29979378)
BMJ. 2021 Mar 29;372:n71. (PMID: 33782057)
Biomark Med. 2014;8(1):15-27. (PMID: 24325222)
Nat Rev Neurosci. 2009 Sep;10(9):635-46. (PMID: 19693028)
Health Inf Manag. 2002 Dec;30(4):1-4. (PMID: 29338340)
Clin Biochem. 2008 Nov;41(16-17):1316-25. (PMID: 18652812)
Expert Rev Neurother. 2019 Jan;19(1):67-81. (PMID: 30451546)
Neurochem Res. 2010 Sep;35(9):1295-301. (PMID: 20499165)
Eur Rev Med Pharmacol Sci. 2013 Jun;17(11):1542-5. (PMID: 23771544)
Bipolar Disord. 2015 Feb;17(1):1-16. (PMID: 25329791)
Int J Neuropsychopharmacol. 2014 Oct;17(10):1599-608. (PMID: 24901538)
Transl Psychiatry. 2018 Mar 13;8(1):61. (PMID: 29531242)
J Proteomics. 2014 May 30;103:15-22. (PMID: 24690516)
Acta Neuropsychiatr. 2018 Apr;30(2):70-78. (PMID: 28399943)
Ther Adv Psychopharmacol. 2018 Apr 26;8(9):251-269. (PMID: 30181867)
Int J Dev Neurosci. 2011 May;29(3):311-24. (PMID: 20833242)
Bipolar Disord. 2014 Aug;16(5):531-47. (PMID: 24330342)
Proteomics. 2011 Jan;11(2):261-9. (PMID: 21204253)
Clin Res Cardiol Suppl. 2017 Mar;12(Suppl 1):31-37. (PMID: 28188431)
Nucleic Acids Res. 2021 Jul 2;49(W1):W388-W396. (PMID: 34019663)
Clin Biochem. 2017 Dec;50(18):1118-1125. (PMID: 28662995)
Transl Psychiatry. 2018 Aug 16;8(1):160. (PMID: 30115926)
Front Psychiatry. 2018 Nov 27;9:614. (PMID: 30538645)
Int J Neuropsychopharmacol. 2015 Oct 09;19(3):pyv096. (PMID: 26453695)
J Affect Disord. 2015 Dec 1;188:149-59. (PMID: 26363613)
Anal Bioanal Chem. 2012 Sep;404(4):939-65. (PMID: 22772140)
Front Cell Neurosci. 2017 Feb 14;11:30. (PMID: 28261061)
Protein Cell. 2015 Dec;6(12):908-11. (PMID: 26475628)
Neurobiol Dis. 2006 Jul;23(1):61-76. (PMID: 16549361)
Drug Discov Today. 2005 Feb 15;10(4):267-73. (PMID: 15708745)
J Psychopharmacol. 2011 Feb;25(2):151-96. (PMID: 20142298)
Subcell Biochem. 2008;49:241-68. (PMID: 18751914)
J Biol Chem. 2011 Jul 22;286(29):25443-9. (PMID: 21632532)
JAMA Psychiatry. 2021 Jan 1;78(1):77-90. (PMID: 32857162)
J Cell Mol Med. 2012 Jun;16(6):1184-95. (PMID: 22304330)
Mol Immunol. 2017 Sep;89:73-83. (PMID: 28601358)
Ann Clin Psychiatry. 2011 Feb;23(1):40-7. (PMID: 21318195)
Arch Gen Psychiatry. 2011 Mar;68(3):241-51. (PMID: 21383262)
Proteomics. 2006 Jun;6(11):3414-25. (PMID: 16637010)
Braz J Med Biol Res. 2015 Nov;48(11):973-82. (PMID: 26375446)
Nat Rev Dis Primers. 2018 Mar 08;4:18008. (PMID: 29516993)
Proteome Sci. 2010 Apr 28;8:23. (PMID: 20426826)
Mol Psychiatry. 2020 Apr;25(4):706-718. (PMID: 31666680)
Curr Top Behav Neurosci. 2021;48:215-237. (PMID: 33040314)
Annu Rev Biochem. 2011;80:273-99. (PMID: 21548781)
Braz J Psychiatry. 2020 Sep-Oct;42(5):536-551. (PMID: 32267339)
Eur Arch Psychiatry Clin Neurosci. 2017 Feb;267(1):3-17. (PMID: 27377417)
Parkinsonism Relat Disord. 2019 Jun;63:3-9. (PMID: 30876839)
Cancers (Basel). 2019 Aug 01;11(8):. (PMID: 31374929)
Lancet. 2013 May 11;381(9878):1663-71. (PMID: 23663952)
Front Neurosci. 2017 Sep 07;11:493. (PMID: 28936160)
Biol Psychiatry. 2011 Jan 15;69(2):102-3. (PMID: 21183008)
J Clin Psychiatry. 2010 Dec;71(12):1689-95. (PMID: 21190640)
Brief Bioinform. 2021 Jan 18;22(1):315-333. (PMID: 32020158)
J Proteomics Bioinform. 2009 Oct 2;2:416-438. (PMID: 20473349)
Womens Health (Lond). 2011 Nov;7(6):663-74; quiz 675-6. (PMID: 22040208)
Brain Sci. 2017 Oct 30;7(11):. (PMID: 29084144)
Adv Exp Med Biol. 2019;1118:191-206. (PMID: 30747424)
World J Biol Psychiatry. 2014 Feb;15(2):84-95. (PMID: 23998912)
Transl Psychiatry. 2015 Dec 08;5:e689. (PMID: 26645624)
Protein Sci. 2020 Jan;29(1):28-35. (PMID: 31423653)
Lancet. 2011 Jun 18;377(9783):2093-102. (PMID: 21652063)
Front Psychiatry. 2020 Feb 26;11:71. (PMID: 32174850)
Bipolar Disord. 2016 Aug;18(5):440-50. (PMID: 27566286)
Proteomics. 2011 Jan;11(1):94-105. (PMID: 21182197)
Nature. 2016 Sep 14;537(7620):347-55. (PMID: 27629641)
Behav Res Ther. 2021 Nov;146:103963. (PMID: 34530318)
Int Rev Neurobiol. 2011;101:1-17. (PMID: 22050846)
Eur Arch Psychiatry Clin Neurosci. 2017 Apr;267(3):199-212. (PMID: 27549216)
Rapid Commun Mass Spectrom. 2020 Sep;34 Suppl 3:e8698. (PMID: 31837042)
Chonnam Med J. 2016 Jan;52(1):18-37. (PMID: 26865997)
معلومات مُعتمدة: POCI-01-0145-FEDER-30943 (ref.: PTDC/MEC-PSQ/30943/2017), POCI-01-0145-FEDER-016428 (ref.: SAICTPAC/0010/2015), POCI-01-0145-FEDER-016795 (ref.: PTDC/NEU-SCC/7051/2014) - and UIDB/04539/2020 and UIDP/04539/2020. CS was supported by Ph.D. fellowship SFRH/B Fundação para a Ciência e Tecnologia
فهرسة مساهمة: Keywords: biomarkers; bipolar disorder; human peripheral fluids; mass spectrometry; proteomics
المشرفين على المادة: 0 (Biomarkers)
0 (Proteome)
تواريخ الأحداث: Date Created: 20220528 Date Completed: 20220531 Latest Revision: 20240829
رمز التحديث: 20240830
مُعرف محوري في PubMed: PMC9141521
DOI: 10.3390/ijms23105460
PMID: 35628270
قاعدة البيانات: MEDLINE
الوصف
تدمد:1422-0067
DOI:10.3390/ijms23105460